Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Tjalke A Westra"'
Autor:
Florian Zeevat, Joost J. M. Simons, Tjalke A. Westra, Jan C. Wilschut, Nina M. van Sorge, Cornelis Boersma, Maarten J. Postma
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 3, Pp 481-499 (2024)
Abstract Introduction Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is a rapidly progressing, rare disease that often presents as meningitis or sepsis. It mostly affects infants and adolescents, with high fatality rates or lon
Externí odkaz:
https://doaj.org/article/e533bfc6adb84078b0470a511629ab13
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e65036 (2013)
BACKGROUND: In 2002, vaccination with a serogroup C meningococcal conjugate vaccine (MenC) was introduced in the Netherlands for all children aged 14 months. Despite its success, herd immunity may wane over time. Recently, a serogroup A,C,W135,Y meni
Externí odkaz:
https://doaj.org/article/320b09c5575a479faccaf51ba7997766
Autor:
Robin de Vries, Mirjam Kretzschmar, Joop F P Schellekens, Florens G A Versteegh, Tjalke A Westra, John J Roord, Maarten J Postma
Publikováno v:
PLoS ONE, Vol 5, Iss 10, p e13392 (2010)
BACKGROUND: Despite widespread immunization programs, a clear increase in pertussis incidence is apparent in many developed countries during the last decades. Consequently, additional immunization strategies are considered to reduce the burden of dis
Externí odkaz:
https://doaj.org/article/d23e0776f5f2487b95783594b60afe13
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100340- (2023)
Introduction: Immunocompromised patients (ICP) have an increased risk for infectious diseases. Vaccines could help reduce this risk. However, ICP do not always receive or are reimbursed for the specific vaccinations on which they are dependent in the
Externí odkaz:
https://doaj.org/article/4ac387504a63416588685dc50acecac9
Publikováno v:
Preventive Medicine Reports, 28. Elsevier
In the Netherlands, the Health Council has advised that the human papillomavirus (HPV) vaccination should be offered to both boys and girls. Additionally, boys and men up to the age of 26 years should be included in a catch-up program. In this study,
Publikováno v:
Vaccine, 38(30), 4687-4694. ELSEVIER SCI LTD
Background: Vaccinating girls against human papillomavirus (HPV) infection is a highly effective and cost-effective intervention to provide protection against HPV-induced cancers. Since vaccination coverage rates among girls is modest in the Netherla
Autor:
Maarten J. Postma, Tjalke A Westra, Bob Wilffert, Jos Luttjeboer, Toos Daemen, Auliya A. Suwantika, Jan Wilschut, Didik Setiawan, Jarir Atthobari
Publikováno v:
Expert review of vaccines, 14(4), 589-604. TAYLOR & FRANCIS LTD
Addition of the HPV vaccine to available cytological screening has been proposed to increase HPV-related cancer prevention. A comprehensive review on this combined strategy implemented in the Netherlands is lacking. For this review, we therefore anal
Autor:
Jos Luttjeboer, Jan Wilschut, Maarten J. Postma, Toos Daemen, Hans W. Nijman, Tjalke A Westra
Publikováno v:
Vaccine, 31(37), 3922-3927. ELSEVIER SCI LTD
Despite an effective screening programme, 600-700 women are still diagnosed with cervical cancer in the Netherlands each year. In 2009 a prophylactic vaccine against HPV-type 16 and 18 was implemented in the national immunisation programme to decreas
Publikováno v:
Expert review of pharmacoeconomics & outcomes research, 13(4), 523-547. Taylor & Francis Group
There has been substantial debate on the need for decreasing discounting for monetary and health gains in economic evaluations. Next to the discussion on differential discounting, a way to identify the need for such discounting strategies is through
Publikováno v:
Expert review of vaccines, 11(12), 1415-1428. TAYLOR & FRANCIS LTD
Despite childhood vaccination programs, pertussis remains endemic. To reduce the burden of pertussis, various extended pertussis vaccination strategies have been suggested. The aim of this article is to evaluate dynamic models used to assess the cost